<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" id="deo270059" xml:lang="en" article-type="correction"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">DEN Open</journal-id><journal-id journal-id-type="iso-abbrev">DEN Open</journal-id><journal-id journal-id-type="doi">10.1002/(ISSN)2692-4609</journal-id><journal-id journal-id-type="publisher-id">DEO2</journal-id><journal-title-group><journal-title>DEN Open</journal-title></journal-title-group><issn pub-type="epub">2692-4609</issn><publisher><publisher-name>John Wiley and Sons Inc.</publisher-name><publisher-loc>Hoboken</publisher-loc></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmid">39834876</article-id><article-id pub-id-type="pmc">PMC11745817</article-id><article-id pub-id-type="doi">10.1002/deo2.70059</article-id><article-id pub-id-type="publisher-id">DEO270059</article-id><article-categories><subj-group subj-group-type="overline"><subject>Correction</subject></subj-group><subj-group subj-group-type="heading"><subject>Correction</subject></subj-group></article-categories><title-group><article-title>Correction to &#x0201c;Comparison of remimazolam and midazolam for sedation during colonoscopy in Japanese patients: A propensity score matching analysis&#x0201d;</article-title></title-group><pub-date pub-type="epub"><day>20</day><month>1</month><year>2025</year></pub-date><pub-date pub-type="collection"><month>4</month><year>2025</year></pub-date><pub-date pub-type="pmc-release"><day>20</day><month>1</month><year>2025</year></pub-date><!--PMC Release delay is 0 months and 0 days and was based on the <pub-date pub-type="epub"/>.--><volume>5</volume><issue seq="33">1</issue><issue-id pub-id-type="doi">10.1002/deo2.v5.1</issue-id><elocation-id>e70059</elocation-id><history>
<date date-type="received"><day>06</day><month>1</month><year>2025</year></date>
<date date-type="accepted"><day>06</day><month>1</month><year>2025</year></date>
</history><permissions><!--&#x000a9; 2025 John Wiley & Sons Ltd.--><copyright-statement content-type="article-copyright">&#x000a9; 2025 The Author(s). <italic toggle="yes">DEN Open</italic> published by John Wiley &#x00026; Sons Australia, Ltd on behalf of Japan Gastroenterological Endoscopy Society.</copyright-statement><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an open access article under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link> License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="file:DEO2-5-e70059.pdf"/><related-article related-article-type="corrected-article" ext-link-type="doi" id="RA1" xlink:href="10.1002/deo2.412">10.1002/deo2.412</related-article><counts><fig-count count="0"/><table-count count="2"/><page-count count="1"/><word-count count="413"/></counts><custom-meta-group><custom-meta><meta-name>source-schema-version-number</meta-name><meta-value>2.0</meta-value></custom-meta><custom-meta><meta-name>cover-date</meta-name><meta-value>April 2025</meta-value></custom-meta><custom-meta><meta-name>details-of-publishers-convertor</meta-name><meta-value>Converter:WILEY_ML3GV2_TO_JATSPMC version:6.5.4 mode:remove_FC converted:27.02.2025</meta-value></custom-meta></custom-meta-group></article-meta></front><body><p>Ogura K, Ichijima R, Ikehara H et&#x000a0;al. Comparison of remimazolam and midazolam for sedation during colonoscopy in Japanese patients: A propensity score matching analysis. <italic toggle="yes">DEN Open</italic> 2024; <bold>5</bold>: e412.</p><p>In Tables&#x000a0;<xref rid="deo270059-tbl-0001" ref-type="table">1</xref> and&#x000a0;<xref rid="deo270059-tbl-0002" ref-type="table">2</xref>, the <italic toggle="yes">N</italic>&#x000a0;=&#x000a0;206 for the midazolam group and the <italic toggle="yes">N</italic>&#x000a0;=&#x000a0;60 for the remimazolam group are incorrect. The correct numbers are <italic toggle="yes">N</italic>&#x000a0;=&#x000a0;208 and <italic toggle="yes">N</italic>&#x000a0;=&#x000a0;40. Accordingly, the adverse event rate for the remimazolam group in Table&#x000a0;<xref rid="deo270059-tbl-0002" ref-type="table">2</xref> is <italic toggle="yes">n</italic>&#x000a0;=&#x000a0;1, 2.5%, and the correct <italic toggle="yes">p</italic>&#x02010;value is 0.16.</p><p>The correct Table 1 and Table 2 are as follow.</p><table-wrap position="float" id="deo270059-tbl-0001" content-type="TABLE"><label>TABLE 1</label><caption><p>Before propensity score matching: Background factors.</p></caption><table frame="hsides" rules="groups"><col align="left" span="1"/><col align="char" char=")" span="1"/><col align="char" char=")" span="1"/><col align="char" char="." span="1"/><thead><tr style="border-bottom:solid 1px #000000"><th align="left" rowspan="1" colspan="1"/><th align="left" rowspan="1" colspan="1">
<p>Midazolam group (<italic toggle="yes">N</italic>&#x000a0;= 208)</p>
</th><th align="left" rowspan="1" colspan="1">
<p>Remimazolam group (<italic toggle="yes">N</italic>&#x000a0;= 40)</p>
</th><th align="left" rowspan="1" colspan="1">
<italic toggle="yes">p</italic>&#x02010;value</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Age (years)</td><td align="char" rowspan="1" colspan="1">62.0 (45.0&#x02013;72.0)</td><td align="char" rowspan="1" colspan="1">53 (43.0&#x02013;63.5)</td><td align="char" rowspan="1" colspan="1">&#x0003c;0.01</td></tr><tr><td align="left" rowspan="1" colspan="1">Sex</td><td align="char" rowspan="1" colspan="1"/><td align="char" rowspan="1" colspan="1"/><td align="char" rowspan="1" colspan="1"/></tr><tr><td style="padding-left:10%" align="left" rowspan="1" colspan="1">Male</td><td align="char" rowspan="1" colspan="1">65 (31.3%)</td><td align="char" rowspan="1" colspan="1">20 (50.0%)</td><td align="char" rowspan="1" colspan="1"/></tr><tr><td style="padding-left:10%" align="left" rowspan="1" colspan="1">Female</td><td align="char" rowspan="1" colspan="1">143 (68.7%)</td><td align="char" rowspan="1" colspan="1">20 (50.0%)</td><td align="char" rowspan="1" colspan="1">0.06</td></tr><tr><td align="left" rowspan="1" colspan="1">Height (cm)</td><td align="char" rowspan="1" colspan="1">165.0 (158.9&#x02013;170.0)</td><td align="char" rowspan="1" colspan="1">163.3 (157.9&#x02013;170.0)</td><td align="char" rowspan="1" colspan="1">0.54</td></tr><tr><td align="left" rowspan="1" colspan="1">Weight (kg)</td><td align="char" rowspan="1" colspan="1">62.2 (54.9&#x02013;73.5)</td><td align="char" rowspan="1" colspan="1">60.4 (49.8&#x02013;66.6)</td><td align="char" rowspan="1" colspan="1">0.10</td></tr><tr><td align="left" rowspan="1" colspan="1">BMI</td><td align="char" rowspan="1" colspan="1">23.2 (20.9&#x02013;25.9)</td><td align="char" rowspan="1" colspan="1">22.4 (20.6&#x02013;24.3)</td><td align="char" rowspan="1" colspan="1">0.13</td></tr><tr><td align="left" rowspan="1" colspan="1">ASA class, <italic toggle="yes">n</italic> (%)</td><td align="char" rowspan="1" colspan="1"/><td align="char" rowspan="1" colspan="1"/><td align="char" rowspan="1" colspan="1"/></tr><tr><td style="padding-left:10%" align="left" rowspan="1" colspan="1">I</td><td align="char" rowspan="1" colspan="1">43 (20.7%)</td><td align="char" rowspan="1" colspan="1">21 (52.5%)</td><td align="char" rowspan="1" colspan="1">&#x0003c;0.01</td></tr><tr><td style="padding-left:10%" align="left" rowspan="1" colspan="1">II</td><td align="char" rowspan="1" colspan="1">141 (67.8%)</td><td align="char" rowspan="1" colspan="1">19 (47.5%)</td><td align="char" rowspan="1" colspan="1"/></tr><tr><td style="padding-left:10%" align="left" rowspan="1" colspan="1">III</td><td align="char" rowspan="1" colspan="1">24 (11.5%)</td><td align="char" rowspan="1" colspan="1">0 (0%)</td><td align="char" rowspan="1" colspan="1"/></tr><tr><td style="padding-left:10%" align="left" rowspan="1" colspan="1">IV</td><td align="char" rowspan="1" colspan="1">0 (0%)</td><td align="char" rowspan="1" colspan="1">0 (0%)</td><td align="char" rowspan="1" colspan="1"/></tr><tr><td style="padding-left:10%" align="left" rowspan="1" colspan="1">V</td><td align="char" rowspan="1" colspan="1">0 (0%)</td><td align="char" rowspan="1" colspan="1">0 (0%)</td><td align="char" rowspan="1" colspan="1"/></tr></tbody></table><table-wrap-foot><fn id="deo270059-tbl1-note-0001"><p>
<italic toggle="yes">Note</italic>: Data are presented as median (interquartile range) or number (percentage).</p></fn><fn id="deo270059-tbl1-note-0002"><p>Abbreviations: ASA, American Society of Anesthesiologists; BMI, body mass index.</p></fn></table-wrap-foot><permissions><copyright-holder>John Wiley &#x00026; Sons, Ltd.</copyright-holder></permissions></table-wrap><table-wrap position="float" id="deo270059-tbl-0002" content-type="TABLE"><label>TABLE 2</label><caption><p>Before propensity score matching: Efficacy and safety of sedation.</p></caption><table frame="hsides" rules="groups"><col align="left" span="1"/><col align="char" char=")" span="1"/><col align="char" char=")" span="1"/><col align="char" char="." span="1"/><thead><tr style="border-bottom:solid 1px #000000"><th align="left" rowspan="1" colspan="1"/><th align="left" rowspan="1" colspan="1">
<p>Midazolam group (<italic toggle="yes">N</italic>&#x000a0;= 208)</p>
</th><th align="left" rowspan="1" colspan="1">
<p>Remimazolam group (<italic toggle="yes">N</italic>&#x000a0;= 40)</p>
</th><th align="left" rowspan="1" colspan="1">
<italic toggle="yes">p</italic>&#x02010;value</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Pre&#x02010;colonoscopy dose (mg)</td><td align="char" rowspan="1" colspan="1">2.0 (2.0&#x02013;2.5)</td><td align="char" rowspan="1" colspan="1">3.0 (3.0&#x02013;4.0)</td><td align="char" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Number of additional doses (times)</td><td align="char" rowspan="1" colspan="1">0 (0&#x02013;0)</td><td align="char" rowspan="1" colspan="1">2 (1&#x02013;3)</td><td align="char" rowspan="1" colspan="1">&#x0003c;0.01</td></tr><tr><td align="left" rowspan="1" colspan="1">Total dose (mg)</td><td align="char" rowspan="1" colspan="1">2.0 (2.0&#x02013;3.0)</td><td align="char" rowspan="1" colspan="1">6.0 (5.0&#x02013;7.0)</td><td align="char" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Examination time (min)</td><td align="char" rowspan="1" colspan="1">15.0 (11.0&#x02013;20.0)</td><td align="char" rowspan="1" colspan="1">12.0 (11.0&#x02013;14.0)</td><td align="char" rowspan="1" colspan="1">&#x0003c;0.01</td></tr><tr><td align="left" rowspan="1" colspan="1">Time from the end of colonoscopy until awakening (min)</td><td align="char" rowspan="1" colspan="1">27.0 (10.0&#x02013;34.0)</td><td align="char" rowspan="1" colspan="1">0 (0&#x02013;0)</td><td align="char" rowspan="1" colspan="1">&#x0003c;0.01</td></tr><tr><td align="left" rowspan="1" colspan="1">Time from the end of colonoscopy until discharge (min)</td><td align="char" rowspan="1" colspan="1">40.0 (35.0&#x02013;48.0)</td><td align="char" rowspan="1" colspan="1">0 (0&#x02013;5.0)</td><td align="char" rowspan="1" colspan="1">&#x0003c;0.01</td></tr><tr><td align="left" rowspan="1" colspan="1">Adverse events, <italic toggle="yes">n</italic> (%)</td><td align="char" rowspan="1" colspan="1">0 (0%)</td><td align="char" rowspan="1" colspan="1">1 (2.5%)</td><td align="char" rowspan="1" colspan="1">0.16</td></tr><tr><td align="left" rowspan="1" colspan="1">Hypotension</td><td align="char" rowspan="1" colspan="1">0 (0%)</td><td align="char" rowspan="1" colspan="1">0 (0%)</td><td align="char" rowspan="1" colspan="1">1.0</td></tr><tr><td style="padding-left:10%" align="left" rowspan="1" colspan="1">Hypoxemia (SpO<sub>2</sub>&#x000a0;&#x0003c;&#x000a0;94%)</td><td align="char" rowspan="1" colspan="1">0 (0%)</td><td align="char" rowspan="1" colspan="1">1 (2.5%)</td><td align="char" rowspan="1" colspan="1">0.16</td></tr><tr><td style="padding-left:10%" align="left" rowspan="1" colspan="1">Respiratory depression</td><td align="char" rowspan="1" colspan="1">0 (0%)</td><td align="char" rowspan="1" colspan="1">0 (0%)</td><td align="char" rowspan="1" colspan="1">1.0</td></tr></tbody></table><table-wrap-foot><fn id="deo270059-tbl2-note-0001"><p>
<italic toggle="yes">Note</italic>: Data are presented as median (interquartile range) or number (percentage).</p></fn></table-wrap-foot><permissions><copyright-holder>John Wiley &#x00026; Sons, Ltd.</copyright-holder></permissions></table-wrap><p>We apologize for this error.</p></body></article>